MedTrace Logo

Topical Nitrates for Myofascial Trigger Points

NCT01675700 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2012-08-30

No results posted yet for this study

Summary

The purpose of this study is to determine whether a topical nitroglycerine patch applied daily over a trapezius trigger point can improve patients' symptoms.

If there is improvement, this open label study will help determine the degree of improvement and contribute to the design of a larger double blind placebo controlled trial.

We would consider moving forward to a large randomized trial if:

* The intervention is acceptable to patients (\>= 70%) and
* Compliance is satisfactory (\>=80%) and
* We find preliminary evidence of efficacy, i.e. average reduction in pain of 20mm on the VAS.

Conditions

  • Myofascial Trigger Points

Interventions

DRUG

Nitroglycerin patch

Nitroglycerin 0.1 mg/hr patch

Sponsors & Collaborators

  • GF Strong Rehabilitation Centre

    lead OTHER

Principal Investigators

  • Hubert A Anton, MD · University of British Columbia

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-07-31
Completion
2009-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01675700 on ClinicalTrials.gov